Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

New agents for BPH emerge from Synaptic/Merck & Co. collaboration

April 9, 1998

Expanded indication approved for Proscar

April 8, 1998

YM-905 shows promise as safe and effective treatment for overactive detrusor

April 6, 1998

RS-100975, a prostate-selective alpha-blocker in vitro

April 6, 1998

The alpha1L-adrenoceptor: a new target for BPH therapy

April 6, 1998

American Home Products synthesizes and evaluates new smooth muscle relaxants

April 6, 1998

Takeda claims bicyclic compounds for micturition disorders

April 6, 1998

Dual-action agent for BPH developed at Zeria

April 3, 1998

N-Alkylated saccharins from Merck & Co. with potential in BPH therapy

April 2, 1998

FDA approves DDAVP tablets for nocturnal enuresis in children

April 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
DOJ arrests shed light on Medicare skin substitute controversy
BioWorld MedTech
Much has been made of the recent skyrocketing of Medicare spending on skin substitutes, but a new enforcement action by the U.S. Department of Justice might help...